SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement

Authors: Wang, Ying-Ting, Allen, Robert D., III, Kim, Kenneth, Shafee, Norazizah, Gonzalez, Andrew J., Nguyen, Michael N., Valentine, Kristen M., Cao, Xia, Lu, Lucy, Pai, Chin-I, Johnson, Sachi, Kerwin, Lisa, Zhou, Heyue, Zhang, Yanliang, Shresta, Sujan

Source: In Antiviral Research November 2021 195

Evaluation of Lassa antiviral compound ST-193 in a guinea pig model

Authors: Cashman, Kathleen A., Smith, Mark A., Twenhafel, Nancy A., Larson, Ryan A., Jones, Kevin F., Allen, Robert D., III, Dai, Dongcheng, Chinsangaram, Jarasvech, Bolken, Tove’ C., Hruby, Dennis E., Amberg, Sean M., Hensley, Lisa E., Guttieri, Mary C.

Source: In Antiviral Research 2011 90(1):70-79

Identification of an Rta responsive promoter involved in driving γHV68 v-cyclin expression during virus replication

Authors: Allen, Robert D., III, DeZalia, Mark N., Speck, Samuel H.

Source: In Virology 2007 365(2):250-259

SAR analysis of a series of acylthiourea derivatives possessing broad-spectrum antiviral activity

Authors: Burgeson, James R., Moore, Amy L., Boutilier, Jordan K., Cerruti, Natasha R., Gharaibeh, Dima N., Lovejoy, Candace E., Amberg, Sean M., Hruby, Dennis E., Tyavanagimatt, Shanthakumar R., Allen, Robert D., III, Dai, Dongcheng

Source: In Bioorganic & Medicinal Chemistry Letters 1 July 2012 22(13):4263-4272

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

c-Myb is essential for early T cell development.

Authors: Allen, Robert D. III, Bender, Timothy P., Siu, Gerald

Source: Genes & Development; May 1 1999, Vol. 13 Issue 9, p1073-1078, 6p